Active Ingredient
Docosanol 10%
The following Structured Product Label (SPL) was submitted to the FDA by Meijer, Inc. for the product Docosanol (NDC 41250-867). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient, purpose, uses, warnings, do not use, when using this product, stop use and ask a doctor if, keep out of reach of children., and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Docosanol 10%
Cold sore/fever blister treatment
Allergy Alert: This product may cause a severe allergic reaction. Symptoms may include:
If an allergic reaction occurs, stop use and seek medical help right away.
For external use only
If swallowed, get medical help or contact a Poison Control Center right away.
benzyl alcohol, light mineral oil, propylene glycol, purified water, sucrose distearate, sucrose stearate
Call 1-877-753-3935 Monday-Friday 9AM-5PM EST
Compare to the active ingredient in Abreva®**
Docosanol Cream 10%
COLD SORE/FEVER BLISTER TREATMENT
Non-Prescription medicine to shorten healing time*
Cold sore treatment
For topical use only
NET WT 2 g (0.07 oz)
**This product is not manufactured or distributed by Glaxosmithkline Consumer Healthcare, or of the Registered trademark Abreva®.
* Non-prescription cold sore medicine to shorten healing time and duration of symptpms.
RETAIN THIS INSERT FOR FULL PRODUCT USES, DIRECTIONS AND WARNINGS
DIST. BY MEIJER DISTRIBUTION, INC.
GRAND RAPID, MI 49544
* Please review the disclaimer below.